Form 4: Rallybio Corp's Chief Medical Officer, Steven Ryder, Acquires 180,000 Options

Steven Ryder, Chief Medical Officer of Rallybio Corp, reports the acquisition of 180,000 options in the company's stock.

Summary

• On February 14, 2025, Steven Ryder, the Chief Medical Officer of Rallybio Corp, acquired 180,000 options to purchase common stock.
• The options were granted under the company's 2021 Equity Incentive Plan.
• The exercise price of each option is $0.76.
• The options vest in 48 equal monthly installments, becoming fully vested on February 14, 2029.
• The options expire on February 14, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grant of options is generally viewed as a positive incentive, but it's not a major event.

Positives

• The grant of options to a key executive like the Chief Medical Officer can be seen as an incentive to align their interests with the long-term success of the company.

Industry Context

Option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• The option grant could potentially incentivize the Chief Medical Officer to drive company performance, benefiting shareholders.

Key Dates

Keywords

options, Rallybio Corp, Steven Ryder, Chief Medical Officer, equity incentive plan, Form 4, beneficial ownership